Atlas Trials

Simultaneous Modulated Accelerated Boost Versus Standard Dose Radiotherapy in Esophageal Cancer

Clinical trial NCT02556762 · UNKNOWN

Trial details

NCT number
NCT02556762
Sponsor
Chuangzhen Chen
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Esophageal Cancer
Start date
2015-08-01
Primary completion
2022-03-01
Enrollment
202

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.